A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

被引：0
作者：
Hideo Baba
Naoko Hayashi
Yasunori Emi
Yoshihiro Kakeji
Akinori Egashira
Eiji Oki
Ken Shirabe
Tetsuo Toyama
Takefumi Ohga
Manabu Yamamoto
Hirofumi Hasegawa
Fumiko Kohakura
Hidefumi Higashi
Kiyoshi Niwa
Fumihiko Fujita
Yutaka Ogata
Shunji Kohnoe
Masafumi Inomata
Hironori Samura
Shoji Tokunaga
Yoshihiko Maehara
机构：
[1] Kumamoto University,Department of Gastroenterological Surgery, Graduate School of Medical Sciences
[2] Kyushu University,Department of Surgery and Science, Graduate School of Medical Science
[3] Nakagami Hospital,Department of Surgery
[4] Saiseikai Fukuoka General Hospital,Department of Surgery
[5] Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital,Department of Surgery
[6] Kyusyu Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Surgery
[7] Urasoe General Hospital,Department of Surgery, and Gastroenterological Internal Medicine
[8] Nippon Steel Yawata Memorial Hospital,Department of Surgery
[9] Sameshima Hospital,Department of Surgery
[10] Nagasaki University Graduate School of Biomedical Sciences,Department of Surgery
[11] Kurume University School of Medicine,Department of Surgery
[12] Fukuoka Dental College,Department of General Surgery
[13] Oita University Faculty of Medicine,Department of Surgery 1
[14] University of the Ryukyus,Division of Digestive and General Surgery, Faculty of Medicine
[15] Kyushu University Hospital,Department of Medical Informatics
来源：
Surgery Today | 2011年 / 41卷
关键词：
FOLFOX4; Oxaliplatin; Colorectal cancer; First-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1610 / 1616
页数：6
相关论文
共 101 条
  • [1] Parkin D.M.(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108
  • [2] Bray F.(1994)Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group Cancer 73 556-562
  • [3] Ferlay J.(1989)Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma J Clin Oncol 7 1407-1418
  • [4] Pisani P.(1997)Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer: International Organization for Cancer Chronotherapy Lancet 350 681-686
  • [5] Glimelius B.(2000)Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 18 136-147
  • [6] Hoffman K.(2000)Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial Lancet 355 1041-1047
  • [7] Graf W.(2000)Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938-2947
  • [8] Pahlman L.(2004)A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23-30
  • [9] Sjoden P.O.(1997)Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers Anticancer Drugs 8 876-885
  • [10] Poon M.A.(2003)CTCAE c3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 176-181
12345678910